Human Immunology News Volume 11.04 | Jan 31 2023

    0
    48








    2023-01-31 | HIN 11.04


    Human Immunology News by STEMCELL Technologies
    Vol. 11.04 – 31 January, 2023
    TOP STORY

    Persistent Mutation Burden Drives Sustained Anti-Tumor Immune Responses

    Investigators evaluated mutations in regions of the genome that were unlikely to undergo loss in a pan-cancer analysis across 31 tumor types and eight immunotherapy-treated cohorts of patients with non-small-cell lung cancer, melanoma, mesothelioma, and head and neck cancer.
    [Nature Medicine]

    Full ArticlePress Release
    Get High Cell Purity and Recovery with Lymphoprepâ„¢
    PUBLICATIONSRanked by the impact factor of the journal

    Combined PD-1, BRAF and MEK Inhibition in BRAFV600E Colorectal Cancer: A Phase II Trial

    The authors performed a proof-of-concept single-arm phase II clinical trial of combined PD-1, BRAF and MEK inhibition with sparatlizumab, dabrafenib, and trametinib in 37 patients with BRAFV600E colorectal cancer.
    [Nature Medicine]

    Full ArticlePress Release

    Tissue CD14+CD8+ T Cells Reprogrammed by Myeloid Cells and Modulated by LPS

    Researchers showed that a variable proportion of CD8+ T cells compartmentalized in the human liver co-stained for CD14 and other prototypic myeloid membrane proteins and were enriched in close proximity to CD14high myeloid cells in hepatic zone 2.
    [Nature]

    Full Article

    Association between Age and Survival Trends in Advanced Non–Small Cell Lung Cancer after Adoption of Immunotherapy

    This cohort study was performed in approximately 280 predominantly community-based US cancer clinics and included patients aged 18 years or older who had stage IIIB, IIIC, or IV non-small cell lung cancer.
    [JAMA Oncology]

    Full Article

    Intrathymic Dendritic Cell-Biased Precursors Promote Human T Cell Lineage Specification through IRF8-Driven Transmembrane TNF

    In vitro recapitulation of TNF receptor 2 (TNFR2) signaling, by providing low-density membrane-bound precursor form of the cytokine TNF or a selective TNFR2 agonist, enhanced the generation of human T cell precursors.
    [Nature Immunology]

    Full Article

    Multi-Antigen Spherical Nucleic Acid Cancer Vaccines

    The authors used spherical nucleic acid nanoparticles to investigate how the spatial distribution and placement of two antigen classes affected antigen processing, cytokine production, and the induction of memory.
    [Nature Biomedical Engineering]

    AbstractPress Release

    CD200+ Cytotoxic T Lymphocytes in the Tumor Microenvironment Are Crucial for Efficacious Anti–PD-1/PD-L1 Therapy

    Scientists found an increase in tumor-infiltrating CD200+ cytotoxic T lymphocytes upon PD-1/PD-L1 blockade, with higher proportions of CD200+ T cells positively related to a favorable clinical outcome to anti–PD-1/PD-L1 therapy in three independent cohorts of patients with cancer.
    [Science Translational Medicine]

    Abstract

    Expansion of Interferon Inducible Gene Pool via USP18 Inhibition Promotes Cancer Cell Pyroptosis

    Lower USP18 expression correlated with better survival across human selected cancer types and delayed cancer progression in mouse models.
    [Nature Communications]

    Full Article

    Multiplex Immune Profiling Reveals the Role of Serum Immune Proteomics in Predicting Response to Preoperative Chemotherapy of Gastric Cancer

    The authors collected serum samples from patients with gastric adenocarcinoma before, on, and after preoperative chemotherapy and studied their immune proteomics using an antibody-based proteomics panel.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract

    CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy

    Immune cells from tumor and peripheral blood were isolated from 42 patients with renal cell carcinoma and 5 patients with ovarian cancer. Researchers performed multicolor flow cytometry and RNA-sequencing to characterize the phenotypes and heterogeneity of intratumoral Tregs.
    [CLINICAL CANCER RESEARCH]

    Abstract
    Explore the Science Events Calendar to discover conferences, podcasts, webinars, and more!
    REVIEWS

    Targeting Protein Phosphatases in Cancer Immunotherapy and Autoimmune Disorders

    The authors discuss progress in phosphatase drug discovery, with emphasis on the development of selective modulators that exhibit biological activity, and the roles and regulation of protein phosphatases in immune cells and their potential as targets for immuno-oncology and autoimmunity indications.
    [Nature Reviews Drug Discovery]

    Abstract

    Targeted Modulation of Immune Cells and Tissues Using Engineered Biomaterials

    Scientists review recent advances in biomaterials-based strategies, focusing on targeting of lymphoid tissues, circulating leukocytes, tissue-resident immune cells, and immune cells at disease sites.
    [Nature Reviews Bioengineering]

    Full Article
    INDUSTRY AND POLICY NEWS

    Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine for MPS I Clinical Program

    Immusoft announced that the California Institute for Regenerative Medicine had awarded the company an $8M grant.
    [Immusoft]

    Press Release
    FEATURED EVENT

    Immuno UK

    March 28 – 29, 2023
    London, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Scientist – Asthma & Skin Immunity

    AstraZeneca – Cambridge, England, United Kingdom

    Postdoctoral Researchers – Immuno-Oxylipidome in Atherosclerosis

    Karolinksa Institutet – Solna, Sweden

    Principal Scientist – Immunogenicity

    Novartis – Munich, Germany

    Senior Postdoctoral Research Fellow – Intestinal Health Immunology

    University of Oxford – Oxford, England, United Kingdom

    Research Associate – CAR T Immunotherapy

    Imperial College London – London, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Human Immunology News Twitter